I-Mab Biopharma


I-Mab Biopharma has developed TJM2, a neutralising antibody, as a treatment for patients suffering severe cases of the coronavirus infection.
Rankings by

National Ranking20th
in China Regional Ranking47th
in East Asia Global Ranking1124th
worldwide